These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16938322)

  • 21. Current treatment for venom-induced consumption coagulopathy resulting from snakebite.
    Maduwage K; Isbister GK
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antivenom use in Australia. Premedication, adverse reactions and the use of venom detection kits.
    Sutherland SK
    Med J Aust; 1992 Dec 7-21; 157(11-12):734-9. PubMed ID: 1360618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
    Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
    Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Snake venoms and their toxins: an Australian perspective.
    Hodgson WC; Wickramaratna JC
    Toxicon; 2006 Dec; 48(7):931-40. PubMed ID: 16920171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Snake venoms and antivenoms: critical supply issues.
    Bawaskar HS
    J Assoc Physicians India; 2004 Jan; 52():11-3. PubMed ID: 15633710
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18).
    Isbister GK; Buckley NA; Page CB; Scorgie FE; Lincz LF; Seldon M; Brown SG;
    J Thromb Haemost; 2013 Jul; 11(7):1310-8. PubMed ID: 23565941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Snake antivenom product guidelines in India: "the devil is in the details".
    Simpson ID; Norris RL
    Wilderness Environ Med; 2007; 18(3):163-8. PubMed ID: 17896852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strychnine, ammonia and gunpowder for snakebite--the end of an era.
    Winkel KD
    Med J Aust; 2001 Jun; 174(11):607. PubMed ID: 11453337
    [No Abstract]   [Full Text] [Related]  

  • 30. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25).
    Johnston CI; Ryan NM; O'Leary MA; Brown SG; Isbister GK
    Clin Toxicol (Phila); 2017 Feb; 55(2):115-122. PubMed ID: 27903075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Snake antivenom: Challenges and alternate approaches.
    Alangode A; Rajan K; Nair BG
    Biochem Pharmacol; 2020 Nov; 181():114135. PubMed ID: 32628928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In Africa snake venom antivenins in short supply. Fatal risk for foreign tourists?].
    Mebs D
    MMW Fortschr Med; 2002 Sep; 144(37):57. PubMed ID: 12380345
    [No Abstract]   [Full Text] [Related]  

  • 33. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An examination of the activity of expired and mistreated commercial Australian antivenoms.
    O'Leary MA; Kornhauser RS; Hodgson WC; Isbister GK
    Trans R Soc Trop Med Hyg; 2009 Sep; 103(9):937-42. PubMed ID: 19144367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of immunoturbidimetry to detect venom-antivenom binding using snake venoms.
    O'Leary MA; Maduwage K; Isbister GK
    J Pharmacol Toxicol Methods; 2013; 67(3):177-81. PubMed ID: 23416032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current technology for the industrial manufacture of snake antivenoms.
    León G; Vargas M; Segura Á; Herrera M; Villalta M; Sánchez A; Solano G; Gómez A; Sánchez M; Estrada R; Gutiérrez JM
    Toxicon; 2018 Sep; 151():63-73. PubMed ID: 29959968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bites by foreign venomous snakes in Britain.
    Reid HA
    Br Med J; 1978 Jun; 1(6127):1598-1600. PubMed ID: 656831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.
    Ainsworth S; Menzies SK; Casewell NR; Harrison RA
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008579. PubMed ID: 32817682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical studies of the effectiveness and safety of antivenoms.
    Williams DJ; Habib AG; Warrell DA
    Toxicon; 2018 Aug; 150():1-10. PubMed ID: 29746978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Snake venoms and coagulopathy.
    White J
    Toxicon; 2005 Jun; 45(8):951-67. PubMed ID: 15922768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.